Biosimilars Review & Report's Stan Mehr, Samsung Bioepis' Sang-Jin Pak, Sandoz's Carol Lynch and Mylan's Chrys Kokino talk interchangeability at the AAM meeting. • Source: Sue Sutter
Stay ahead of every shift in generics and biosimilars.
Generics Bulletin brings you the latest updates that matter for the off-patent industry.
